Literature DB >> 17889865

Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method.

Ana Cobo1, Masashigue Kuwayama, Sonia Pérez, Amparo Ruiz, Antonio Pellicer, José Remohí.   

Abstract

OBJECTIVE: To evaluate the outcome of oocyte vitrification using the Cryotop method, observed in an egg donation program by simultaneously evaluating embryos derived from vitrified and fresh oocytes coming from the same stimulated cycle.
DESIGN: Cohort prospective randomized study.
SETTING: Instituto Valenciano de Infertilidad (IVI) Valencia, Spain. PATIENT(S): Thirty oocyte donors and 30 recipients with informed consents. INTERVENTION(S): Vitrification by the Cryotop method. Warming 1 hour after vitrification. Microinjection of surviving MII and fresh oocytes, evaluation of fertilization, embryo development, and clinical results. MAIN OUTCOME MEASURE(S): Survival, fertilization, and cleavage rate. Embryo quality, pregnancy rate (PR), and implantation rate. RESULT(S): Survival rate observed was 96.7%. There was no difference in fertilization rates (76.3% and 82.2%), day 2 cleavage (94.2% and 97.8%), day 3 cleavage (80.8% and 80.5%), and blastocyst formation (48.7% and 47.5%) for vitrified and fresh oocytes, respectively. Embryo quality on day 3 and on day 5-6 were similar for vitrification and fresh oocyte group (80.8% vs. 80.5% and 81.1% vs. 70%, respectively). A total of 23 embryo transfers were carried out in the vitrification group. Pregnancy rates, implantation rates, miscarriage rates, and ongoing PR were 65.2%, 40.8%, 20%, and 47.8%, respectively. CONCLUSION(S): The Cryotop method preserves the potential of vitrified oocytes to fertilize and further develop, which is similar, when evaluated simultaneously, to fresh counterparts. Excellent clinical outcome indicates the possible use of this technology for egg donation programs, as well as a high potential for establishing oocyte banking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889865     DOI: 10.1016/j.fertnstert.2007.05.050

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  97 in total

Review 1.  Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature.

Authors:  Giuliano M Bedoschi; Felipe Oliveira de Albuquerque; Rui Alberto Ferriani; Paula Andrea Navarro
Journal:  J Assist Reprod Genet       Date:  2010-05-09       Impact factor: 3.412

2.  Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation.

Authors:  Mi Kyoung Kim; Dong Ryul Lee; Ji Eun Han; You Shin Kim; Woo Sik Lee; Hyung Jae Won; Ji Won Kim; Tae Ki Yoon
Journal:  J Assist Reprod Genet       Date:  2011-11-25       Impact factor: 3.412

Review 3.  Prevention of ovarian damage and infertility in young female cancer patients awaiting chemotherapy--clinical approach and unsolved issues.

Authors:  Katharina Hancke; Vladimir Isachenko; Evgenia Isachenko; Jürgen M Weiss
Journal:  Support Care Cancer       Date:  2011-09-23       Impact factor: 3.603

Review 4.  Recent advances in oocyte and ovarian tissue cryopreservation and transplantation.

Authors:  Kenny A Rodriguez-Wallberg; Kutluk Oktay
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-02-01       Impact factor: 5.237

5.  Cryo-survival, fertilization and early embryonic development of vitrified oocytes derived from mice of different reproductive age.

Authors:  Jie Yan; Joao Suzuki; Xiaomin Yu; Frederick W K Kan; Jie Qiao; Ri-Cheng Chian
Journal:  J Assist Reprod Genet       Date:  2010-07-17       Impact factor: 3.412

6.  Oncofertility in Canada: cryopreservation and alternative options for future parenthood.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

7.  Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study.

Authors:  Yin-Mei Chen; Qian-Rong Qi; Qing-Zhen Xie; Yi-Fan Yang; Yi Xia; Xiao-Dan Zhou
Journal:  Curr Med Sci       Date:  2018-06-22

Review 8.  New approaches to female fertility preservation.

Authors:  J Domingo; Y Ayllón; S Domingo; A Cobo; J Crespo; A Pellicer
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

9.  Single embryo and oocyte lipid fingerprinting by mass spectrometry.

Authors:  Christina R Ferreira; Sergio A Saraiva; Rodrigo R Catharino; Jerusa S Garcia; Fabio C Gozzo; Gustavo B Sanvido; Luiz Fernando A Santos; Edson G Lo Turco; José Henrique F Pontes; Andréa C Basso; Ricardo P Bertolla; Roberto Sartori; Monique M Guardieiro; Felipe Perecin; Flávio V Meirelles; Juliano R Sangalli; Marcos N Eberlin
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

10.  The presence of 1 mM glycine in vitrification solutions protects oocyte mitochondrial homeostasis and improves blastocyst development.

Authors:  Deirdre Zander-Fox; Kara S Cashman; Michelle Lane
Journal:  J Assist Reprod Genet       Date:  2012-12-18       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.